Physician Assistant, Medical · Macon, GA
NPI
1508980947
Since 2007
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
308 Coliseum Dr, Suite 200
Macon, GA, 31217
Phone (478) 742-2180
Groups this clinician bills Medicare through
Medicare paid, 2024
$449K
9,823 services
Medicare patients, 2024
1,492
Average age 75
Drug cost, 2024
$3.6M
1,724 prescriptions
Company payments, 2025
$4,973
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chad A Perry was code 17003 (destruction skin lesion), 3,253 times for 501 patients. In total Chad A Perry billed 9,823 services in 37 codes, and Medicare paid $449K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,253 | 501 | $3.82 | $12K |
| 99213 Office E&M - Established | Office | 1,854 | 1,327 | $49.42 | $92K |
| 17000 Destruction Skin Lesion | Office | 733 | 591 | $29.51 | $22K |
| 11102 Skin Biopsy | Office | 719 | 586 | $53.37 | $38K |
| 11103 Skin Biopsy | Office | 255 | 151 | $30.40 | $7,752 |
| 17004 Destruction Skin Lesion | Office | 220 | 175 | $92.51 | $20K |
| 17263 Destruction Skin Lesion | Office | 129 | 99 | $99.97 | $13K |
| 99203 Office E&M - New | Office | 116 | 116 | $49.67 | $5,762 |
| 99212 Office E&M - Established | Office | 102 | 98 | $32.69 | $3,335 |
| 96372 Injection Administration | Office | 73 | 35 | $8.23 | $601 |
| 11104 Skin Biopsy | Office | 57 | 55 | $70.73 | $4,031 |
| 17273 Destruction Skin Lesion | Office | 56 | 48 | $115.38 | $6,462 |
| 69100 Other Organ Systems | Office | 50 | 47 | $42.92 | $2,146 |
| 17262 Destruction Skin Lesion | Office | 44 | 39 | $85.08 | $3,743 |
| 17272 Destruction Skin Lesion | Office | 32 | 28 | $89.61 | $2,868 |
By year: 2022 $511K for 10,380 services; 2023 $432K for 9,629 services; 2024 $449K for 9,823 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chad A Perry prescribed most often to Medicare patients was Triamcinolone Acetonide, with 258 prescriptions and refills. In total Chad A Perry wrote 1,724 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 258 | 320 | 159 | $3,944 |
| Betamethasone Dipropionate Generic | 139 | 154 | 87 | $4,269 |
| Dupixent Syringe Dupilumab | 97 | 97 | 18 | $374K |
| Dupixent Pen Dupilumab | 95 | 96 | 16 | $355K |
| Ketoconazole Generic | 89 | 91 | 49 | $1,214 |
| Clobetasol Propionate Generic | 73 | 80 | 33 | $2,880 |
| Minocycline Hcl Generic | 60 | 60 | 33 | $776 |
| Tremfya Guselkumab | 53 | 99 | 14 | $725K |
| Terbinafine Hcl Generic | 53 | 63 | 30 | $497 |
| Fluorouracil Generic | 53 | 54 | 47 | $3,344 |
| Hydrocortisone Generic | 52 | 59 | 30 | $213 |
| Spironolactone Generic | 49 | 66 | 13 | $534 |
| Fluocinonide Generic | 44 | 48 | 26 | $2,185 |
| Valacyclovir Valacyclovir Hcl | 41 | 65 | 17 | $2,399 |
| Metronidazole Generic | 38 | 40 | 17 | $2,335 |
Brand drugs: 495 claims; generic drugs: 1,229 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chad A Perry $4,973 ($4,973 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $1,066.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 59 | $1,066 |
| Janssen Biotech, Inc. JNJ | 32 | $893 |
| Regeneron Healthcare Solutions, Inc. REGN | 25 | $735 |
| Genzyme Corporation SNY | 14 | $513 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $377 |
| Incyte Corporation INCY | 16 | $346 |
| UCB, Inc. UCB.BR | 20 | $335 |
| Lilly USA, LLC LLY | 10 | $242 |
| Revance Therapeutics, Inc. | 1 | $143 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.